According to a receint article in FierceMedicalDevices, Medtronic ($MDT) believes its pump technology could pair well with the next generation of Alzheimer’s treatments, and the company is on the hunt for pharmaceutical partners.
Lisa Shafer, Medtronic’s director of CNS drug delivery, told Bloomberg that less than 1% of intravenous treatments can get past the blood-brain barrier on their own, but, if paired with the company’s already-on-the-market pumps, Alzheimer’s drugs could be delivered straight to the brain.
Medtronic has proof of concept for the potential pairing, and now it needs only to recruit partners, Shafer said.
Read more of this September 18, 2012 article by Damian Garde at FierceMedicalDevices : Medtronic seeks pharma partners for Alzheimer’s treatments – FierceMedicalDevices